Research Briefing | Apr 27, 2021

Global | Coronavirus Watch: Downside risks ease

Rising global Covid infections remain a key focus, but the recent surge is not automatically grounds for us to slash our near-term forecasts. Indeed, the strength of the initial business and consumer surveys in April potentially lessens the downside risks to the near-term economic outlook.

Vaccine developments over recent months have also clearly reduced uncertainties. Over the past six months, we have pushed up our forecasts for the level of global GDP by the middle of the decade, albeit to a lesser degree than the IMF. But the fund’s especially large revisions compared to ours reflect its previously more pessimistic assessment of the medium-term outlook.

We maintain our view that emerging markets will suffer greater medium-term scarring than advanced economies. But the gap could be narrowed if the pace of vaccine production allows for faster than anticipated rollouts in EMs.

 

Tags: CoronavirusCoronavirus vaccineCoronavirus WatchEconomic impactGlobal economyLockdown
Back to Resource Hub

Related Services

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

The ruling Liberal Democratic Party's (LDP) landslide election victory on Sunday doesn't change our expectation of a primary fiscal deficit of 2%-3% of GDP in FY2026-FY2028 – we still see the deficit only starting to decline from FY2029. We also keep our view that the 10-year Japanese government bond (JGB) yield will be at 2.3% at end-2026 and 2.5% at end-2027 and beyond.
US and Chinese strength won’t boost all other economies

US and Chinese strength won’t boost all other economies

Upward revisions to US and Chinese GDP growth in Q4 meant that the previously anticipated soft end to 2025 failed to materialise.